Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,200.3
27.3 (0.86%)

 

  • STI Straits Times Index
    3,200.3
    27.3 (0.86%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,587.5
    9.1 (0.58%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,610.7
    -26.8 (-0.09%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,418.9
    -22.4 (-0.65%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,357.8
    26.5 (0.09%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,928.3
    -41.9 (-0.70%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,799.6M
  • Value: 1,479.4M
  • Rise: 165
  • Fall: 169
  • Unch: 435

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Shen Yao0.008-
Renaissance United0.003+0.001
ESR-REIT0.390-0.020
Sembcorp Marine0.198-0.002
SPH1.520-0.270
Jiutian Chemical0.100+0.001
VCPlus0.032-0.001
Blumont0.005-
MM2 Asia0.063-
YZJ Shipbldg SGD1.530+0.010

World Indices

World Indices
Name Last Change
Nasdaq 13,632.8 +50.4
HSI 28,610.7 -26.8
HSCEI 10,699.0 -57.4
Jakarta 5,928.3 -41.9
Nikkei 225 29,357.8 +26.4
SSE Comp 3,418.9 -22.4
Shanghai A 3,583.5 -23.5
Shanghai B 248.2 -0.4
KOSPI 3,197.2 +18.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

AYTU BIOPHARMA INC AYTU BIOPHARMA
Updated on 06 May 2021 (End of trading day)
Last (USD): 5.860 Change: -0.040 High: 5.920 Remarks: -
Change (%): -0.68 Low: 5.720
Open 5.900 Yesterday's Close 5.9
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 404,454 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.58027 Trailing EPS (USD) e -0.95040 NAV (USD) b 4.8009
PE a - Trailing PE f - Price / NAV b 1.2206
Dividend (USD) d - Cash In Hand (USD) g 2.6535 Issued & Paid-up Shares c 23,473,000
Dividend Yield (%) d - Price / Cash In Hand g 2.208 Treasury Shares h -
Market Cap (M) 137.552 Enterprise Value (M) 87.503
Piotroski F Score 2 Exchange Code AYTU Par Value ( $ ) n.a.
52 Weeks Volatility (%) 69.87 Free Float (%) 86.2
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 20 Apr 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 20 Oct 2017.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference AYTU BIOPHARMA INC NASDAQ 137.552 - - 1.2206 -
Industry Pharmaceuticals: Major NASDAQ 2,378.778 73.000 64.206 3.1254 0.029
Local Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 140,412.275 43.595 35.064 9.7305 2.562
Local Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 128,622.735 9.163 9.163 1.6686 2.627
Local Peer ROYALTY PHARMA PLC NASDAQ 24,921.948 25.560 25.560 5.1718 0.467
Local Peer CUREVAC NV NASDAQ 17,531.070 - - 20.1419 -
Local Peer VIATRIS INC NASDAQ 16,836.355 - - 0.7335 -
Local Peer REPLIGEN CORP NASDAQ 10,169.411 169.699 202.938 - -
Local Peer ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS NASDAQ 7,143.428 - - 6.9610 -
Local Peer IMMUNITYBIO INC NASDAQ 6,132.903 - - 52.2349 -
Local Peer ALLAKOS INC NASDAQ 5,305.457 - - 8.1074 -
Local Peer GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 NASDAQ 4,697.807 6.662 6.662 0.7516 -
Local Peer I MAB SPON ADS EACH REP 2.3 ORD SHS NASDAQ 4,271.913 62.613 62.614 4.9648 -
Local Peer LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS NASDAQ 3,702.859 - - 13.2125 -
Other Local Peers HUTCHISON CHINA MEDITECH SPON ADS EACH REPR 5 ORD SHS (NASDAQ), APELLIS PHARMACEUTICALS INC (NASDAQ), TURNING POINT THERAPEUTICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), REATA PHARMACEUTICALS INC (NASDAQ), KARUNA THERAPEUTICS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), GENERATION BIO CO (NASDAQ), CEREVEL THERAPEUTICS HLDGS INC (NASDAQ), ATEA PHARMACEUTICALS INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), KRONOS BIO INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), CULLINAN ONCOLOGY INC (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), PETIQ INC (NASDAQ), MIND MEDICINE (MINDMED) INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), KINNATE BIOPHARMA INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), ESSA PHARMA INC (NASDAQ), PRAXIS PRECISION MEDICINES INC (NASDAQ), SILVERBACK THERAPEUTICS INC (NASDAQ), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), CONNECT BIOPHARMA HLDGS LTD ADS EACH REP ONE ORD SHARE (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), ALIGOS THERAPEUTICS INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), OLEMA PHARMACEUTICALS INC (NASDAQ), BOLT BIOTHERAPEUTICS INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), PHARVARIS NV (NASDAQ), ANNEXON INC (NASDAQ), CHINOOK THERAPEUTICS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), VERU INC (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), ACHILLES THERAPEUTICS PLC ADS EACH REPR 1 SHARE SPON (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), TARSUS PHARMACEUTICALS INC (NASDAQ), ADAGENE INC SPON ADS EACH REP 1.25 ORD SHS (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), CLENE INC (NASDAQ), VECTIVBIO HLDG AG (NASDAQ), BIOMEA FUSION INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), 89BIO INC (NASDAQ), EVOLUS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), AC IMMUNE SA (NASDAQ), VACCITECH PLC ADR EACH REPR 1 ORD SH SPON (NASDAQ), CODIAK BIOSCIENCES INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), NEXIMMUNE INC (NASDAQ), ATHENEX INC (NASDAQ), GRITSTONE ONCOLOGY INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), INOZYME PHARMA INC (NASDAQ), ANGION BIOMEDICA CORP (NASDAQ), BEYONDSPRING INC (NASDAQ), DURECT CORP (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), RENEO PHARMACEUTICALS INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), ORPHAZYME A/S SPON ADS REP 1 ORD SHS (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), IMMUNIC INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), IMPEL NEUROPHARMA INC (NASDAQ), 4D PHARMA PLC SPONS ADR EACH REP 8 ORD SHS (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), MUSTANG BIO INC (NASDAQ), OBSEVA SA (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), TRICIDA INC (NASDAQ), VINCERX PHARMA INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), NOVAN INC (NASDAQ), POLYPID LTD (NASDAQ), LANTERN PHARMA INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), YUMANITY THERAPEUTICS INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), GENPREX INC (NASDAQ), QILIAN INTERNATIONAL HLDG GROUP LTD (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), 180 LIFE SCIENCES CORP (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), GALECTO INC (NASDAQ), LIQUIDIA CORPORATION (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), ELEDON PHARMACEUTICALS INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), IMARA INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), EYENOVIA INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), MEDIWOUND LTD (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), GRAYBUG VISION INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), F-STAR THERAPEUTICS INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), ENTERA BIO LTD (NASDAQ), PROPHASE LABS INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), UNIVERSE PHARMACEUTICALS INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), PURPLE BIOTECH LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), BAUDAX BIO INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), INHIBIKASE THERAPEUTICS INC (NASDAQ), OCUPHIRE PHARMA INC (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), REVIVA PHARMACEUTICALS HOLDINGS INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), MANNATECH INC (NASDAQ), PANBELA THERAPEUTICS INC (NASDAQ), VIRIOS THERAPEUTICS INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), NLS PHARMACEUTICS LTD (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), PETROS PHARMACEUTICALS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), PAINREFORM LTD (NASDAQ), TELIGENT INC NEW (NASDAQ), VALLON PHARMACEUTICALS INC (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), MILLENDO THERAPEUTICS INC (NASDAQ), VIRPAX PHARMA INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 441,726.516 30.021 29.224 6.7097 2.372
Global Peer PFIZER INC NYSE 218,608.090 22.734 22.734 3.4569 3.896
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 215,497.691 26.539 27.002 4.2653 2.178
Global Peer ABBVIE INC NYSE 204,861.466 44.965 40.106 - 4.170
Global Peer MERCK & CO INC NYSE 196,808.290 27.849 28.003 - 3.188
Global Peer ELI LILLY AND COMPANY NYSE 185,945.551 30.022 30.520 26.9539 1.523
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 143,999.128 - - 3.8292 2.867
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 131,523.952 20.411 20.411 12.6352 1.813
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 95,370.945 12.936 14.047 4.6502 5.458
Global Peer WUXI APPTEC HKEx 524,919.315 158.158 158.158 13.6251 0.200
Other Global Peers TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), HANSOH PHARMA (HKEx), INNOVENT BIO (HKEx), CANSINOBIO-B (HKEx), SINOPHARM (HKEx), JUNSHI BIO (HKEx), SH PHARMA (HKEx), REMEGEN-B (HKEx), CMS (HKEx), AKESO-B (HKEx), BROOKLYN IMMUNO THERAPEUTICS INC (NYSE American), HYGEIA HEALTH (HKEx), INNOCARE-B (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), BAIYUNSHAN PH (HKEx), CHINARES PHARMA (HKEx), CHINAGRANDPHARM (HKEx), HENLIUS (HKEx), TRAD CHI MED (HKEx), SIMCERE PHARMA (HKEx), EVEREST MED-B (HKEx), HEPALINK (HKEx), SSY GROUP (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), ADC THERAPEUTICS SA (NYSE), OCUMENSION-B (HKEx), CSTONE PHARMA-B (HKEx), UNITED LAB (HKEx), ANTENGENE-B (HKEx), SCICLONE PHARMA (HKEx), ZYMEWORKS INC (NYSE), TONGRENTANGCM (HKEx), IMMUNOTECH-B (HKEx), Kimia Farma Tbk. (IDX), CKLIFE SCIENCES (HKEx), ZHAOKE OPHTH-B (HKEx), IGBB (Bursa), HUA MEDICINE-B (HKEx), STARPHARMA HOLDINGS LIMITED (ASX), SHINEWAY PHARM (HKEx), Soho Global Health Tbk. (IDX), FUSEN PHARM (HKEx), PYC THERAPEUTICS LIMITED (ASX), RACE ONCOLOGY LTD (ASX), AFT PHARMACEUTICALS LTD (ASX), TOT BIOPHARM-B (HKEx), DAWNRAYS PHARMA (HKEx), BSTEAD (Bursa), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), PHARMA (Bursa), IP (SET), LANNETT CO INC (NYSE), CRESO PHARMA LTD (ASX), RECCE PHARMACEUTICALS LTD (ASX), ANNOVIS BIO INC (NYSE American), ZHONGZHIPHARM (HKEx), CH BIOTECH SER (HKEx), IX Biopharma (SGX), NOXOPHARM LTD (ASX), Merck Tbk. (IDX), NEW RAY MEDIC (HKEx), KOTRA (Bursa), NC HEALTHCARE (HKEx), EXOPHARM LTD (ASX), Phapros Tbk. (IDX), PAK FAH YEOW (HKEx), CHARMACY PHAR (HKEx), MODERN CHI MED (HKEx), Hyphens Pharma (SGX), NOVA (Bursa), ONCOSIL MEDICAL LIMITED (ASX), BIOHLDG (Bursa), PALLA PHARMA LTD (ASX), NEP INTERLONG (HKEx), MEDLAB CLINICAL LIMITED (ASX), TIMBER PHARMACEUTICALS INC (NYSE American), AGEX THERAPEUTICS INC (NYSE American), WAI YUEN TONG (HKEx), EXTRAWELL PHAR (HKEx), TBG DIAGNOSTICS LTD (ASX), INVION LTD (ASX), JCT (SET), SANAI HEALTH GP (HKEx), PURAPHARM (HKEx), IMMURON LIMITED (ASX), ACRUX (ASX), PHARMAXIS (ASX), SUNZEN (Bursa), TALI DIGITAL LIMITED (ASX), ISLAND PHARMACEUTICALS LTD (ASX), SINOLIFE UTD (HKEx), PASHUN INT'L (HKEx), FIJI KAVA LTD (ASX), SUDA PHARMACEUTICALS LTD (ASX), CELLMID LIMITED (ASX), FARMAFORCE LTD (ASX), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.760
-11.48 %
10 Days --0.930
-13.70 %
20 Days --1.370
-18.95 %
Medium Term Return 3 Months --2.300
-28.19 %
6 Months --4.340
-42.55 %
1 Year --9.440
-61.70 %
Long Term Return 2 Years --16.240
-73.48 %
3 Years --59.400
-91.02 %
Annualised Return Annualised --
-55.22 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 5.830 - 19.000 Change From 1 Year Low +0.030 % Change From 1 Year Low (%) +0.51
Change From 1 Year High -13.140 % Change From 1 Year High (%) -69.16
2 Years Range 3.352 - 29.900 Change From 2 Years Low +2.508 % Change From 2 Years Low (%) +74.82
Change From 2 Years High -24.040 % Change From 2 Years High (%) -80.40
5 Years Range 3.352 - 1,364.000 Change From 5 Years Low +2.508 % Change From 5 Years Low (%) +74.82
Change From 5 Years High -1358.140 % Change From 5 Years High (%) -99.57
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Aytu Biopharma, Inc. is a specialty pharmaceutical company, which focuses on identifying, acquiring, and commercializing novel products. Its products include Natesto, Tuzistram, ZolpiMist and MiOXSYS. The company was founded on August 9, 2002 and is headquartered in Englewood, CO.

Historical Price Data

Date Open High Low Close Volume VWAP
06 May 2021 5.900 5.920 5.720 5.860 404,454 -
05 May 2021 6.180 6.191 5.830 5.900 656,996 -
04 May 2021 6.300 6.390 6.010 6.110 567,406 -
03 May 2021 6.560 6.600 6.270 6.300 366,271 -
30 Apr 2021 6.590 6.730 6.470 6.620 420,912 -
29 Apr 2021 6.850 6.850 6.550 6.710 294,393 -
28 Apr 2021 6.750 6.840 6.610 6.820 238,674 -
27 Apr 2021 7.080 7.120 6.710 6.750 312,173 -
26 Apr 2021 6.810 7.200 6.800 7.060 302,176 -
23 Apr 2021 6.680 6.830 6.580 6.790 244,150 -
22 Apr 2021 6.770 6.880 6.615 6.650 250,860 -
21 Apr 2021 6.390 6.790 6.300 6.760 312,327 -
20 Apr 2021 6.500 6.540 6.270 6.440 381,923 -
19 Apr 2021 6.420 6.540 6.280 6.500 316,367 -
16 Apr 2021 6.540 6.560 6.350 6.490 426,632 -
15 Apr 2021 6.890 6.900 6.550 6.640 345,190 -
14 Apr 2021 6.690 7.030 6.570 6.820 322,016 -
13 Apr 2021 6.830 6.850 6.532 6.750 474,660 -
12 Apr 2021 7.200 7.260 6.800 6.840 371,015 -
09 Apr 2021 7.110 7.470 7.050 7.230 362,172 -
08 Apr 2021 6.950 7.220 6.830 7.170 402,871 -
07 Apr 2021 6.940 7.140 6.880 6.935 447,105 -
Summary
Current 2 Weeks
(23 Apr 2021 to 06 May 2021)
6.680 7.200 5.720 5.860 3,807,605 -
Previous 2 Weeks
(09 Apr 2021 to 22 Apr 2021)
7.110 7.470 5.720 6.650 3,563,162 -
4 Weeks from
(11 Mar 2021 to 08 Apr 2021)
7.850 9.510 5.720 7.170 21,071,822 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.